Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at the 2023 ACR Convergence meeting in San Diego, CA.
Bimekizumab in Active AS_ 5 Year Study
INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA
Overlap of Inflammatory and Degenerative Features in Radiographic axSpA
People with AxSpa Need More Sleep
Does Diet Matter in RA_ ITIS vs Mediterranean diet
EHR Algorithms Identify PsA Patients
JAK1 TYK2 in RA
Older RA Patients Just Aren't Getting Treated
PR3+ in Lupus Nephritis
Racial and Ethnic Differences in Efficacy of Beliumumab in SLE
Steroids and MACE in RA
Unravelling the Mechanism of Clots with JAK Inhibitors
Cannabinoid Receptor in RA Patients
Cardiac Troponin T and MACE Events in RA
Imaging Updates in SpA
Impact of Tofacitinib on Skeletal Muscle in RA
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
Treatments in SpA
Identifying New Biomarkers in the Pathogenesis of SLE-PAH
No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
Simulated JAK Trials to Counter ORAL Survelliance
The FOREMOST Study_ Apremilast in PsA
The SMART Study_ Split Dose Oral Methotrexate
Upadacitinib for Pain_ Is That Real_
Head to Head Comparison of Tofacitinib and TLL-018 in RA
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
People with RA and Long COVID Had Worse Pre-COVID RA Symptoms
Reproductive History, HPV Vaccination Among Women with SLE and RA
Secukinumab vs.
Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen in the car, airplane, anywhere! We also reach more listeners through reviews from our users. Consider leaving a review!